Kognitive Dysfunktion bei Krebs erfassen – Assessment: FACT-Cog3

Kognitive Beeinträchtigungen sind häufige Begleiter einer Krebsdiagnose. Das Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog) Version 3 bietet wertvolle Einblicke in spezifische Herausforderungen der Betroffenen im Alltag. Der FACT-Cog3 bietet für die Ergotherapie eine valide und reliable Grundlage, um diese Herausforderungen zu erfassen und gezielte Interventionen abzuleiten.

Publication History

Article published online:
09 January 2025

• Literaturverzeichnis

• 1 Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., Hrsg. Krebs in Deutschland für 2019/2020. 14. Ausgabe. Berlin: 2023.
• 2 Binarelli G, Lange M, Santos MD. et al Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility study. BMC Complement Med Ther 2024; 24 (01) 209
• 3 Janelsins M C, Kesler SR, Ahles TA. et al Prevalence, mechanisms, and management of cancer-related cognitive impairment. Nature Reviews Clinical Oncology 2014; 11 (10) 555-564
• 4 Haywood D, Dauer E, Baughman FD. et al “Is My Brain Ever Going to Work Fully Again?": Challenges and Needs of Cancer Survivors with Persistent Cancer-Related Cognitive Impairment. Cancers (Basel) 2023; 15 (22) 5331
• 5 Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv 2018; 12 (04) 537-559
• 6 Hermelink K, Voigt V, Kaste J. et al Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress. Journal of the National Cancer Institute. 2015; 107: 07 Doi:10.1093/jnci/djv099
• 7 King S, Green H J. Psychological Intervention for Improving Cognitive Function in Cancer Survivors: A Literature Review and Randomized Controlled Trial. Frontiers in Oncology 2015; 5 (03) 431
• 8 McNeil C. Treating Chemobrain: Rehabilitation Therapies Emerge. Journal of the National Cancer Institute 2012; 104 (22) 1691-1692
• 9 FACIT Group. The patient's perspective in focus (2024). www.facit.org/facitorg-history Stand: 11.08.2024
• 10 Oliveira AF, Santos IM, Fernandes S, et al. Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population. BMC Psychol 2022; 10 (01) 305
• 11 Joly F, Lange M, Rigal O. et al French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 2012; 20 (12) 3297-3305
• 12 Cheung YT, Lim SR, Shwe M. et al Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast Cancer. Value in Health 2013; 16 (06) 1001-1013
• 13 Hassan M, Barakat Z, Fares Y. et al Cognitive functioning in women with breast cancer: psychometric properties of the Arabic version of the Functional Assessment of Cancer Therapy-Cognitive Function Tool. Health Qual Life Outcomes 2023; 21 (01) 9
• 14 Park JH, Bae SH, Jung YS. et al The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer. Support Care Cancer 2015; 23 (09) 2695-2703
• 15 Atasavun Uysal S, Yildiz Kabak V, Karakas Y. et al Investigation of the validity and reliability of the Turkish version of the Functional Assessment of Cancer Therapy - Cognitive Function in cancer patients Palliat Support Care. 2021; Doi: 10.1017/S147895152100136X.
• 16 Koch V, Wagner L, Green H. Assessing neurocognitive symptoms in cancer patients and controls: psychometric properties of the FACT-Cog3. Current Psychology 2021; 42